cremophor el has been researched along with cyclosporine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 20 (54.05) | 18.2507 |
2000's | 14 (37.84) | 29.6817 |
2010's | 3 (8.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ilhan, M; Tuncer, M; Yaris, E | 1 |
Chester, A; Mankad, P; O'Neil, G; Slavik, Z; Spatenka, J; Yacoub, M | 1 |
Brat, DJ; Brimijoin, S; Windebank, AJ | 1 |
Yee, GC | 1 |
Beliveau, R; Jetté, L; Leclerc, JM; Murphy, GF | 1 |
Chan, HS; Doyle, J; Greenberg, ML; Koren, G; Liau-Chu, M; Theis, JG | 1 |
Osann, K; Slater, L; Stupecky, M; Sweet, P; Wetzel, M | 1 |
Tuncer, M; Yaris, E | 1 |
Baker, RM; Brecher, ML; Chervinsky, DS; Hoelcle, MJ; Tebbi, CK | 1 |
Lodge, NJ | 1 |
Blexrud, MD; de Groen, PC; Windebank, AJ | 1 |
Cornblatt, B; Lee, EJ; Levy, C; Ross, DD; Schiffer, CA; Sridhara, R; Tong, Y; Wooten, PJ | 1 |
Alvestrand, A; Larsson, M; Tibell, A | 1 |
Ge, X; McCarthy, ET; Savin, VJ; Sharma, M; Sharma, R | 1 |
Windebank, AJ | 1 |
Dahlback, M; Eirefelt, S; Karlsson, BW; Lundin, PD; Pierzynowski, SG; Podlesny, J; Siwinska-Golebiowska, H; Taljanski, W; Westrom, BR | 1 |
Brinkmann, T; Kleesiek, K; Körfer, R; Körner, M; Prohaska, W; Tiemann, C | 1 |
Koren, G; Liau-Chu, M; Theis, JG | 1 |
Michaud, LB | 1 |
Canada, AL; Ross, HJ; Slater, LM | 1 |
Escousse, A; Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS | 1 |
Cloarec, A; Cornaire, G; Decourt, S; Houin, G; Legendre, JY; Saivin, S; Woodley, JF | 1 |
Bessard, G; Deveaux, G; Devillier, P; Hardy, G; Sessa, C; Stanke-Labesque, F | 1 |
Sparreboom, A; van Zuylen, L; Verweij, J | 1 |
Meyer, D; van der Bijl, P; van Eyk, AD | 1 |
Bardelmeijer, HA; Beijnen, JH; Koopman, FJ; Malingré, MM; Ouwehand, M; Rosing, H; Schellens, JH; Schot, ME; Ten Bokkel Huinink, WW; Van Tellingen, O | 1 |
Engelbrecht, AH; Meyer, D; Van Der Bijl, P; Van Eyk, AD | 1 |
Beijnen, JH; Boogerd, W; Cleypool, C; Kemper, EM; Mos, HA; van Tellingen, O; van Zandbergen, AE | 1 |
Dyck, J; English, D; Kerjner, A; Lai, JC; Loo, S; McDonald, PC; McManus, BM; Moghadasian, MH; Tranfield, EM; Walker, DC; Wilson, JE; Wong, D | 1 |
Chang, EJ; Mun, KC | 1 |
Furukawa, H; Ishizaki, J; Jin, M; Miyamoto, K; Mizuhara, Y; Nomura, M; Shimada, T; Yokogawa, K | 1 |
Aliabadi, HM; Lavasanifar, A; Mahmud, A; Sharifabadi, AD | 1 |
Connor, HD; Forman, DT; Lemasters, JJ; Li, X; Mason, RP; Thurman, RG; Zhong, Z | 1 |
Chen, JS; Chen, PM; Chu, Z; Figg, WD; Gardner, ER; Liau, CT; Lin, YC; Sparreboom, A; Wang, HM; Yang, MH | 1 |
Atilla, P; Bolay, H; Cakar, AN; Dalkara, T; Emre-Aydıngöz, S; Erdem, SR; Tuncer, M | 1 |
Dufour, S; Geny, B; Kindo, M; Lampert, E; Mettauer, B; N' Guessan, BB; Ribera, F; Sanchez, H; Ventura-Clapier, R; Zoll, J | 1 |
Ehinger, KH; Elmér, E; Hansson, MJ; Sjövall, F | 1 |
3 review(s) available for cremophor el and cyclosporine
Article | Year |
---|---|
Dosage forms of cyclosporine.
Topics: Administration, Oral; Capsules; Cyclosporine; Drug Stability; Glycerol; Humans; Injections, Intravenous; Solutions | 1991 |
Methods for preventing reactions secondary to Cremophor EL.
Topics: Anaphylaxis; Chemistry, Pharmaceutical; Cyclosporine; Drug Compounding; Glycerol; Humans; Pharmaceutical Vehicles | 1997 |
Role of formulation vehicles in taxane pharmacology.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemistry, Pharmaceutical; Cyclosporine; Drug Hypersensitivity; Drug Resistance, Multiple; Glycerol; Humans; Micelles; Neoplasms; Nervous System Diseases; Paclitaxel; Polysorbates; Surface-Active Agents | 2001 |
5 trial(s) available for cremophor el and cyclosporine
Article | Year |
---|---|
Anaphylactoid reactions in children receiving high-dose intravenous cyclosporine for reversal of tumor resistance: the causative role of improper dissolution of Cremophor EL.
Topics: Adolescent; Anaphylaxis; Antineoplastic Combined Chemotherapy Protocols; Azo Compounds; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Ethanol; Glycerol; Humans; Immunosuppressive Agents; Infusions, Intravenous; Pharmaceutical Vehicles; Premedication; Rhabdomyosarcoma; Solubility; Solvents; Statistics, Nonparametric | 1995 |
The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Area Under Curve; Cyclosporine; Drug Combinations; Feces; Glycerol; Humans; Intestinal Absorption; Neoplasms; Paclitaxel; Pharmaceutical Vehicles; Polysorbates; Solvents | 2001 |
Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glycerol; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Paclitaxel | 2008 |
Oxidative capacities of cardiac and skeletal muscles of heart transplant recipients: mitochondrial effects of cyclosporin-A and its vehicle Cremophor-EL.
Topics: Cyclosporine; Dose-Response Relationship, Drug; Electron Transport; Electron Transport Chain Complex Proteins; Female; Glycerol; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mitochondria, Heart; Mitochondria, Muscle; Muscle, Skeletal; Myocardium; Oxygen Consumption; Pharmaceutical Vehicles; Transplants | 2014 |
Bioequivalence and tolerability assessment of a novel intravenous ciclosporin lipid emulsion compared to branded ciclosporin in Cremophor ® EL.
Topics: Adolescent; Adult; Area Under Curve; Biological Availability; Chemistry, Pharmaceutical; Cross-Over Studies; Cyclosporine; Emulsifying Agents; Excipients; Fat Emulsions, Intravenous; Female; Glycerol; Half-Life; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; South Africa; Therapeutic Equivalency; Young Adult | 2013 |
29 other study(ies) available for cremophor el and cyclosporine
Article | Year |
---|---|
Actions of cyclosporin A preparation and Cremophor-EL in rabbit mesenteric artery and thoracic aorta in vitro.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Cyclosporine; Drug Synergism; Glycerol; In Vitro Techniques; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Phenylephrine; Rabbits; Solvents; Vasoconstriction; Vasodilation | 1992 |
Acute effects of cyclosporin and cremophor EL on endothelial function and vascular smooth muscle in the isolated rat heart.
Topics: Animals; Coronary Circulation; Cyclosporine; Endothelium, Vascular; Glycerol; Heart; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Perfusion; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains | 1992 |
Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma.
Topics: Animals; Cell Differentiation; Cyclosporine; Glycerol; Mice; Neurites; Neuroblastoma; Pharmaceutical Vehicles; Tumor Cells, Cultured; Video Recording | 1992 |
Interaction of drugs with P-glycoprotein in brain capillaries.
Topics: Affinity Labels; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Blood-Brain Barrier; Brain; Capillaries; Cyclosporine; Cyclosporins; Drug Interactions; Glycerol; In Vitro Techniques; Iodine Radioisotopes; Male; Prazosin; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 1995 |
Comparison of cyclosporin A, verapamil, PSC-833 and cremophor EL as enhancing agents of VP-16 in murine lymphoid leukemias.
Topics: Animals; Cell Survival; Cyclosporine; Cyclosporins; Drug Synergism; Etoposide; Glycerol; Leukemia L1210; Leukemia P388; Mice; Survival Analysis; Tumor Cells, Cultured; Verapamil | 1995 |
The effect of indomethacin on cyclosporin A- and its solvent-induced inhibition of endothelium-dependent relaxation and the drug-induced contraction of rabbit isolated arteries.
Topics: Acetylcholine; Animals; Cyclosporine; Endothelium, Vascular; Glycerol; In Vitro Techniques; Indomethacin; Male; Pharmaceutical Vehicles; Rabbits; Vasoconstriction; Vasodilation | 1995 |
Reversal of C1300 murine neuroblastoma multidrug resistance by cremophorEL, a solvent for cyclosporin A.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Chromatography, High Pressure Liquid; Clone Cells; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Glycerol; Harringtonines; Homoharringtonine; Intracellular Fluid; Mice; Neuroblastoma; Pharmaceutical Vehicles; Solvents; Tumor Cells, Cultured | 1993 |
Direct vasoconstrictor effects of sandimmune (cyclosporine A) are mediated by its vehicle cremophor EL: inhibition by the thromboxane A2/prostaglandin endoperoxide receptor antagonist ifetroban.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dose-Response Relationship, Drug; Glyburide; Glycerol; In Vitro Techniques; Male; Oxazoles; Pharmaceutical Vehicles; Propionates; Rabbits; Receptors, Thromboxane; Ricinoleic Acids; Vasoconstrictor Agents | 1994 |
Potential neurotoxicity of the solvent vehicle for cyclosporine.
Topics: Animals; Cyclosporine; Demyelinating Diseases; Ethanol; Female; Ganglia, Spinal; Glycerol; Humans; Nervous System; Pharmaceutical Vehicles; Pregnancy; Rats; Rats, Sprague-Dawley | 1994 |
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
Topics: Cell Survival; Cyclosporine; Daunorubicin; Drug Resistance; Drug Synergism; Female; Glycerol; Humans; Leukemia, Myeloid, Acute; Male; Tumor Cells, Cultured | 1994 |
Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat.
Topics: Animals; Cyclosporine; Drug Carriers; Emulsions; Glomerular Filtration Rate; Glycerol; Infusions, Intravenous; Kidney; Kidney Diseases; Male; Rats; Rats, Wistar; Solubility; Soybean Oil | 1993 |
Cyclosporine protects glomeruli from FSGS factor via an increase in glomerular cAMP.
Topics: Albumins; Animals; Cyclic AMP; Cyclosporine; Glomerulosclerosis, Focal Segmental; Glycerol; Humans; Kidney Glomerulus; Male; Microscopy, Electron; Permeability; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1996 |
The vehicle for cyclosporine is neurotoxic in vitro.
Topics: Animals; Axons; Cells, Cultured; Cyclosporine; Demyelinating Diseases; Glycerol; Humans; Neurons; Oligodendroglia; Pharmaceutical Vehicles | 1997 |
Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.
Topics: Aerosols; Aging; Animals; Biological Availability; Cyclosporine; Female; Glycerol; Half-Life; Lung; Male; Rats; Rats, Sprague-Dawley; Trachea | 1997 |
Effect of cyclosporine A on the release of tissue factor pathway inhibitor from endothelial cells in heart transplant patients and cell culture.
Topics: Adolescent; Adult; Calcimycin; Calcium; Cell Division; Cells, Cultured; Cyclosporine; Endothelium, Vascular; Female; Glycerol; Heart Transplantation; Humans; Ionophores; Lipoproteins; Male; Middle Aged; Pharmaceutical Vehicles; von Willebrand Factor | 1997 |
Mechanism of anaphylactoid reactions: improper preparation of high-dose intravenous cyclosporine leads to bolus infusion of Cremophor EL and cyclosporine.
Topics: Anaphylaxis; Chemistry, Pharmaceutical; Cyclosporine; Drug Compounding; Ethanol; Glycerol; Humans; Pharmaceutical Vehicles; Solutions | 1997 |
Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cyclosporine; Cytokines; Disease Models, Animal; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Glycerol; Growth Substances; Humans; Immunosuppressive Agents; Leukemia; Mice; Paclitaxel; Respiratory Tract Neoplasms; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 1997 |
Acute cyclosporine A-induced nephrotoxicity: a rabbit model.
Topics: Acute Disease; Animals; Cyclosporine; Glycerol; Kidney; Kidney Diseases; Male; Rabbits; Renal Circulation; Surface-Active Agents | 2000 |
Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cardiotonic Agents; Cyclosporine; Digoxin; Glycerol; In Vitro Techniques; Intestinal Absorption; Intestine, Small; L-Lactate Dehydrogenase; Micelles; Polysorbates; Rats; Surface-Active Agents | 2000 |
Cyclosporine A and cremophor EL induce contractions of human saphenous vein: involvement of thromboxane A2 receptor-dependent pathway.
Topics: Biphenyl Compounds; Cyclosporine; Fibrinolytic Agents; Glycerol; Heptanoic Acids; Humans; Immunosuppressive Agents; In Vitro Techniques; Lipoxygenase Inhibitors; Muscle Contraction; Muscle, Smooth, Vascular; Pharmaceutical Vehicles; Receptors, Thromboxane; Saphenous Vein | 2000 |
Effects of three penetration enhancers on transcorneal permeation of cyclosporine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzalkonium Compounds; Biological Availability; Biological Transport; Cornea; Cyclosporine; Dimethyl Sulfoxide; Glycerol; Humans; Immunosuppressive Agents; Middle Aged; Permeability; Pharmaceutical Vehicles | 2001 |
Comparative permeability of human and rabbit corneas to cyclosporin and tritiated water.
Topics: Animals; Benzalkonium Compounds; Cornea; Culture Techniques; Cyclosporine; Dimethyl Sulfoxide; Female; Frozen Sections; Glycerol; Humans; Immunosuppressive Agents; Male; Models, Biological; Permeability; Rabbits; Time Factors; Tritium; Water | 2002 |
Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.
Topics: Acridines; Animals; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Brain; Chromatography, High Pressure Liquid; Clinical Trials as Topic; Cyclosporine; Cyclosporins; Dose-Response Relationship, Drug; Female; Glycerol; Mice; Mice, Knockout; Paclitaxel; Tetrahydroisoquinolines; Time Factors | 2003 |
Ultrastructural evidence of early endothelial damage in coronary arteries of rat cardiac allografts.
Topics: Animals; Aorta; Coronary Vessels; Cyclosporine; Disease Models, Animal; Endothelium, Vascular; Glycerol; Heart Transplantation; Immunosuppressive Agents; Male; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Pharmaceutical Vehicles; Rats; Rats, Inbred Lew; Silver Staining; Surface-Active Agents | 2003 |
Effect of melatonin on the malondialdehyde level of neutrophils in cyclosporine-treated rats.
Topics: Animals; Cyclosporine; Glycerol; Male; Malondialdehyde; Melatonin; Neutrophils; Rats; Rats, Sprague-Dawley | 2004 |
Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A.
Topics: Adsorption; Animals; Blood Cells; Blood Vessels; Cyclosporine; Glycerol; Male; Rats; Rats, Wistar | 2005 |
Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Topics: Cyclosporine; Glycerol; Micelles; Pharmaceutical Vehicles; Polyesters; Solubility | 2005 |
Reduction of ciclosporin and tacrolimus nephrotoxicity by plant polyphenols.
Topics: Aldehydes; Animals; Camellia sinensis; Chromatography, High Pressure Liquid; Cyclosporine; Flavonoids; Free Radicals; Glomerular Filtration Rate; Glycerol; Immunohistochemistry; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Olive Oil; Phenols; Phytotherapy; Plant Oils; Polyphenols; Rats; Rats, Sprague-Dawley; Tacrolimus | 2006 |
Cyclosporine A-induced acute hepatotoxicity in guinea pigs is associated with endothelin-mediated decrease in local hepatic blood flow.
Topics: Animals; Bosentan; Cyclosporine; Dose-Response Relationship, Drug; Endothelins; Female; Glycerol; Guinea Pigs; Liver; Liver Circulation; Male; Peptides, Cyclic; Sulfonamides | 2011 |